LIMNW NASDAQ
Liminatus Pharma, Inc. Warrants
1W: +27.3%
1M: -16.2%
3M: -42.6%
YTD: +52.9%
1Y: -85.8%
$0.05
+0.00 (+11.01%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.3M
52W Range0.03-0.1949
Volume1,214
Avg Volume5,054
Beta0.74
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChris Kim
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2025-04-30
Websiteliminatuspharma.com
12611 Hiddencreek Way
Cerritos, CA 90703
US
Cerritos, CA 90703
US
213 273 5453
About Liminatus Pharma, Inc. Warrants
Liminatus Pharma, Inc., situated in La Palma, California, is an immuno-oncology firm actively engaged in clinical trials, dedicated to pioneering innovative treatments for various cancers.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Lemons II Philip Way | 0 | — | 2025-07-10 | |
| Baek Richard JaiHwan | 0 | — | 2025-07-10 | |
| Iris Acquisition Hol | 0 | — | 2025-04-30 | |
| KH Feelux Co., Ltd | 0 | — | 2025-04-30 | |
| Valetudo Therapeutic | 0 | — | 2025-04-30 |